Assistant Researcher | Shanghai Jiao Tong University, China
Dr. Xiao-cao Miao, a 32-year-old accomplished biomedical researcher, specializes in tumor immune microenvironment, bioinformatics, and environmental microbiology. Currently an Assistant Researcher at the Shanghai Cancer Institute (Renji Hospital), she holds a Ph.D. in Biology from Shanghai Jiao Tong University. Dr. Miao has led several high-impact projects including studies on diabetes pathogenesis, pancreatic cancer mechanisms, and microbial risks in water systems. She integrates cutting-edge multi-omics analysis with experimental validation, contributing significantly to precision medicine. Her technical expertise spans single-cell sequencing, PCR, microscopy, and bioinformatics tools. Dr. Miao is a prolific author with multiple SCI-indexed publications in journals like Genome Medicine and Journal of Hazardous Materials. A recipient of prestigious academic honors including the Outstanding Graduate Award and Young Scholars Forum prizes, she is passionate about translational research bridging genomics, immunology, and public health. Dr. Miao exemplifies scientific innovation with societal impact.
Profile
Scopus
Orcid
🎓 Education
 Xiao-cao Miao began her academic journey at Shanghai Ocean University (2011–2015), earning a B.S. in Food Science. She enriched her undergraduate experience with a one-year exchange program at the Ocean University of China (2013–2014). She then pursued her M.S. in Food Engineering at Shanghai University (2015–2017), where she delved into food safety and biochip technologies. Her academic curiosity evolved into advanced biomedical research, culminating in a Ph.D. in Biology from Shanghai Jiao Tong University (2017–2022). During her doctoral studies, she explored microbial resistance and waterborne pathogens, blending environmental microbiology with high-throughput omics approaches. This multidisciplinary background laid the foundation for her expertise in tumor microenvironment and bioinformatics. Her education seamlessly bridges food science, environmental risk, and molecular biology, enabling her to approach health challenges holistically. With each academic stage, she mastered both theoretical insight and hands-on research, emerging as a well-rounded scientist prepared for impactful biomedical innovation.
🧪 Experience
 Since 2022, Dr. Miao has served as an Assistant Researcher at the Shanghai Cancer Institute, affiliated with Renji Hospital. She is Principal Investigator of major projects funded by Shanghai and national grants, including cutting-edge research on pancreatic cancer genetics, immune microenvironment, and cross-disease analysis with neurological disorders. Her leadership in multi-omics data integration and causal inference techniques is critical in unraveling gene-disease relationships. Previously, she was a key contributor to microbial risk assessments in drinking water systems, publishing high-impact work on chlorine resistance and pathogen virulence. She also co-developed a multiplex PCR platform to detect dairy pathogens during her early career (2016–2025 project timeline). Throughout her career, she has demonstrated expertise in molecular biology, grant writing, team management, and scientific publishing. Her combined industry-academic experience highlights her adaptability, cross-disciplinary collaboration, and commitment to applying research for real-world health challenges.
🏅 Awards & Honors
 Dr. Xiao-cao Miao has received numerous accolades for her scientific excellence. She was honored as an Outstanding Graduate at Shanghai Jiao Tong University and received First Prize at the 1st Urban Water Industry Doctoral Forum. Her work also earned her the Excellent Award and Second Prize in SJTU’s 9th and 8th Young Scholars Forums respectively. Recognized for community engagement, she won First Prize in the 2018 SJTU Summer Social Practice. She actively participates in sports, securing 6th place in the 200m Dragon Boat Race at the 16th Shanghai Municipal Games and Second Prize at the 2020 Yangtze River Delta Elite Dragon Boat Competition. During her master’s studies, she received a National Third-Class Scholarship and was named an Outstanding Graduate Student at Shanghai University. These distinctions reflect her well-rounded character, blending academic brilliance, leadership, and teamwork both in research and extracurricular activities.
🔬 Research Focus
 Dr. Miao’s research is centered on the tumor immune microenvironment, bioinformatics, and microbial ecology. She applies advanced multi-omics methods—including single-cell transcriptomics, ATAC-seq, and genome-wide association studies—to unravel mechanisms driving pancreatic cancer and metabolic disorders like diabetes. Her projects explore how HLA gene families modulate immune infiltration and cancer progression, offering potential therapeutic targets. She employs Mendelian randomization to identify causal links between neurological disorders and pancreatic cancer, promoting drug repurposing opportunities. Previously, she led investigations into chlorine-resistant pathogens in drinking water systems and biofilm-related microbial dynamics. With strong expertise in molecular biology, sequencing, and computational analysis, she aims to integrate environmental and genomic data to advance personalized medicine. Her work is highly translational, bridging environmental microbiology and cancer immunology to develop predictive models and interventions. Overall, her research transforms big data into actionable insights for disease prevention and therapeutic innovation.
âś… Conclusion
Dr. Xiao-cao Miao demonstrates exceptional promise as a woman scientist leading innovative, data-driven biomedical research. Her strong academic background, independent project leadership, and notable scientific output make her a worthy candidate for the Women Researcher Award. With her current trajectory and continued interdisciplinary integration, she is well-positioned to become a thought leader in tumor biology and translational bioinformatics.
Publication
-
Cell-type-specific cis-eQTLs in pancreatic cell types identify novel risk genes for type 2 diabetes | (Year not provided) | Xiaocao Miao, Hui Li, Qing Li, Lei Zhu, Yanqiu Yu, Tao Chen, Dongxue Li, Zhigang Zhang
-
The role of pipe biofilms on dissemination of viral pathogens and virulence factor genes in a full-scale drinking water supply system | 2022 | Xiaocao Miao, Chenxu Liu, Mingkun Liu, Xue Han, Lingling Zhu, Xiaohui Bai
-
Intrinsic chlorine resistance of bacteria modulated by glutaminyl-tRNA biosynthesis in drinking water supply systems | 2022 | Xiaocao Miao, Xue Han, Xiaohui Bai
-
Characterization of the synergistic relationships between nitrification and microbial regrowth in chloraminated drinking water supply systems | 2021 | Xiaocao Miao, Xiaohui Bai
-
Bacterial community assembly and beta-lactamase (bla) genes regulation in a full-scale chloraminated drinking water supply system | 2022 | Xiaocao Miao, Lingling Zhu, Xiaohui Bai
-
Behavior of last resort antibiotic resistance genes (mcr-1 and blaNDM-1) in a drinking water supply system and their possible acquisition by the mouse gut flora | 2020 | Hira Khan, Xiaocao Miao, Mingkun Liu, Shakeel Ahmad, Xiaohui Bai
-
Multiplex PCR for dairy pathogens | 2018 | Miao, X., Chen, W., Shi, C., et al.
-
Advances in biochips for food detection | 2017 | Miao, X., Chen, W., Zhang, J., et al.